NCT00914433View on ClinicalTrials.gov

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

April 30, 2010

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

TPI 1100

1 dose only increasing dose

Sponsors

Lead Sponsor

Syntara
All Listed Sponsors
lead

Syntara

INDUSTRY

NCT00914433 - Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers | Biotech Hunter | Biotech Hunter